Journal
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES
Volume 15, Issue 6, Pages 1287-1298Publisher
IVYSPRING INT PUBL
DOI: 10.7150/ijbs.33218
Keywords
lncRNA; p53; cancer; therapy
Categories
Funding
- National Natural Science Foundation of China [81874183, 81602533, 81672845, 81872304]
- Education Department of Jiangsu Province [15KJA320006]
- Jiangsu Provincial Medical Youth Talent Project [QNRC2016776]
- Project of Invigorating Health Care through Science, Technology and Education from Jiangsu
Ask authors/readers for more resources
p53 is the major mediator of the tumor suppressor response. It participates in apoptosis and senescence and can respond to DNA damage. As a crucial sequence-specific transcription factor, p53 regulates the expression of many genes, such as small noncoding RNAs (ncRNAs), microRNAs, and long ncRNAs (lncRNAs). Given the emergence of novel and high-throughput sequencing technologies, many lncRNAs have been discovered. LncRNAs may function as vital gene regulators in a variety of biological processes through extensive mechanisms. Recently, lncRNAs have been demonstrated to be associated with the p53 regulatory pathway. In this review, we discuss the current and fast growing knowledge about the influence of lncRNAs to the p53 signaling pathway, the different mechanisms by which they affect gene expression in cancer. Our findings show that p53-associated lncRNAs may be used as biomarkers for cancer diagnosis or targets for disease therapy.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available